poisar

Stocks · News reference

UBS Maintains Buy on C.H. Robinson Worldwide, Lowers Price Target to $204

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CHRW
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    C.H. Robinson Q3 Earnings Top Estimates on Pricing and Lean AI Gains

    C.H. Robinson (CHRW) delivered impressive Q3 2026 results with earnings up 28.6% to $1.80 per share and revenues surging 29.5% to $5.36 billion, beating consensus estimates. The company maintained its 2026 profit guidance and expects $300 million in annual synergies from its proposed $5.8 billion RXO acquisition. Strong performance was driven by higher freight pricing, AI productivity gains, and market share growth, though operating cash flow declined due to unfavorable working capital changes.

    CHRWDALJBHTUAL

  2. Analyst Actions on C.H. Robinson Worldwide

    Multiple financial firms, including Citigroup, UBS, Jefferies, and Raymond James, adjusted their price targets for C.H. Robinson Worldwide on October 29, 2026.

    CHRW